Trial Profile
Somatostatin Receptor Imaging in Patients With Suspected Cardiac Sarcoidosis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Pentetreotide (Primary)
- Indications Heart disorders; Sarcoidosis
- Focus Diagnostic use
- 04 Sep 2018 Status changed from recruiting to completed.
- 28 Aug 2017 Planned End Date changed from 1 Dec 2017 to 1 Aug 2018.
- 28 Aug 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Aug 2018.